Celestica (CLS) Cash & Equivalents (2016 - 2026)

Celestica (CLS) has reported Cash & Equivalents for 11 consecutive years, with $535.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 70.71% year-over-year to $535.7 million in Q2 2026; TTM through Jun 2026 was $535.7 million, a 70.71% increase from a year earlier, with the FY2025 full-year figure at $595.6 million, up 40.7% from the prior year.
• Cash & Equivalents was $535.7 million for Q2 2026 at Celestica, up from $378.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $595.6 million in Q4 2025 and troughed at $303.0 million in Q1 2025.
• A 5-year average of $400.0 million and a median of $374.5 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents declined 4.95% in 2022 and soared 70.71% in 2026, its largest moves.
• Over 5 years, Cash & Equivalents stood at $374.5 million in 2022, then fell by 1.09% to $370.4 million in 2023, then rose by 14.28% to $423.3 million in 2024, then surged by 40.7% to $595.6 million in 2025, then retreated by 10.06% to $535.7 million in 2026.
• The last three Cash & Equivalents figures came in at $535.7 million (Q2 2026), $378.0 million (Q1 2026), and $595.6 million (Q4 2025), per Business Quant data.